Skip to main content
Top
Published in: Reactions Weekly 1/2022

01-06-2022 | Case report

Antibacterials/potassium-permanganate/sirolimus

Treatment failure and off-label use: case report

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Sharma S, et al. Novel use of topical sirolimus in the treatment of hyperkeratotic cutaneous capillary venous malformations associated with multiple cerebral cavernous malformations: a case report. Australasian Journal of Dermatology 63 (Suppl.): 79, May 2022. Available from: URL: https://doi.org/10.1111/ajd.11_13832 [abstract] Sharma S, et al. Novel use of topical sirolimus in the treatment of hyperkeratotic cutaneous capillary venous malformations associated with multiple cerebral cavernous malformations: a case report. Australasian Journal of Dermatology 63 (Suppl.): 79, May 2022. Available from: URL: https://​doi.​org/​10.​1111/​ajd.​11_​13832 [abstract]
Metadata
Title
Antibacterials/potassium-permanganate/sirolimus
Treatment failure and off-label use: case report
Publication date
01-06-2022
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-17747-0

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Phenytoin

Case report

Cefepime

Case report

Rifampicin